These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12956000)

  • 1. Is ABO blood grouping a gene marker for vitiligo?
    Olasode OA
    Niger J Med; 2002; 11(4):193. PubMed ID: 12956000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "ABO blood groups and vitiligo".
    Mohan L; Singh G; Kaur P; Pandey SS; Mohan R; Niyogi AK
    Indian J Dermatol; 1982 Apr; 27(2):60-2. PubMed ID: 7129532
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased micronucleus frequency in phytohaemagglutinin-stimulated blood cells of patients with vitiligo.
    Donmez-Altuntas H; Sut Z; Ferahbas A; Hamurcu Z; Demirtas H
    J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):162-7. PubMed ID: 18211408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No association between secretor status of ABO blood group antigens and juvenile periodontitis.
    Frías MT; López NJ
    Acta Odontol Latinoam; 1994-1995; 8(2):9-15. PubMed ID: 11885229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of malondialdehyde and antioxidants in the blood of patients with vitiligo of age group 11-20 years.
    Jain D; Misra R; Kumar A; Jaiswal G
    Indian J Physiol Pharmacol; 2008; 52(3):297-301. PubMed ID: 19552063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ABO polymorphism in blood donors in Morocco].
    Habti N; Nourichafi N; Benchemsi N
    Transfus Clin Biol; 2004 Apr; 11(2):95-7. PubMed ID: 15120106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue estimation of protein gene product 9.5 (PGP 9.5) expression and apoptosis in vitiligo.
    Aroni K; Grapsa A; Lazaris AC; Kavantzas N; Kordosis T; Patsouris ES
    Int J Dermatol; 2008 Sep; 47(9):911-7. PubMed ID: 18937653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of ABO blood groups and vitiligo.
    Kareemullah L; Taneja V; Begum S; Sarma PK; Baig HA
    J Med Genet; 1977 Jun; 14(3):211-3. PubMed ID: 881714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association study between catalase gene polymorphisms and the susceptibility to vitiligo in Korean population.
    Park HH; Ha E; Uhm YK; Jin SY; Kim YJ; Chung JH; Lee MH
    Exp Dermatol; 2006 May; 15(5):377-80. PubMed ID: 16630078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression analysis of melanocortin system in vitiligo.
    Kingo K; Aunin E; Karelson M; Philips MA; Rätsep R; Silm H; Vasar E; Soomets U; Kõks S
    J Dermatol Sci; 2007 Nov; 48(2):113-22. PubMed ID: 17651944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between ABO blood groups and skin cancers.
    Tursen U; Tiftik EN; Unal S; Gunduz O; Kaya TI; Camdeviren H; Ikizoglu G
    Dermatol Online J; 2005 Dec; 11(3):44. PubMed ID: 16409940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of gastroduodenal disease phenotype with ABO blood group and Helicobacter pylori virulence-specific serotypes.
    Sharara AI; Abdul-Baki H; ElHajj I; Kreidieh N; Kfoury Baz EM
    Dig Liver Dis; 2006 Nov; 38(11):829-33. PubMed ID: 16931196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nondeletional ABO*O alleles frequently cause blood donor typing problems.
    Wagner FF; Blasczyk R; Seltsam A
    Transfusion; 2005 Aug; 45(8):1331-4. PubMed ID: 16078922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of acetylsalicylic acid on the release rates of leukotrienes B4 and C4 from cultured skin melanocytes of active vitiligo.
    Zailaie MZ
    Saudi Med J; 2004 Oct; 25(10):1439-44. PubMed ID: 15494818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible association of the CD4 gene polymorphism with vitiligo in an Iranian population.
    Zamani M; Tabatabaiefar MA; Mosayyebi S; Mashaghi A; Mansouri P
    Clin Exp Dermatol; 2010 Jul; 35(5):521-4. PubMed ID: 19843086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of single nucleotide polymorphisms of Nrf2 promoter region with susceptibility to vitiligo].
    Zhou MN; Xu AE; Lu LJ; Li YW; Zhao DK; Guan CP
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):969-72. PubMed ID: 18756969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A weak blood group A phenotype caused by a translation-initiator mutation in the ABO gene.
    Seltsam A; Das Gupta C; Bade-Doeding C; Blasczyk R
    Transfusion; 2006 Mar; 46(3):434-40. PubMed ID: 16533287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathologic features in vitiligo.
    Kim YC; Kim YJ; Kang HY; Sohn S; Lee ES
    Am J Dermatopathol; 2008 Apr; 30(2):112-6. PubMed ID: 18360112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo.
    Gavalas NG; Akhtar S; Gawkrodger DJ; Watson PF; Weetman AP; Kemp EH
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1586-91. PubMed ID: 16729966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Definition of maximum permissible errors for major physical parameters affecting the result of microplate ABO-RH1 blood grouping].
    Bouix O; Sanchez P; Reifenberg JM
    Transfus Clin Biol; 2007 Aug; 14(3):348-51. PubMed ID: 17482497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.